(Q37435425)
Statements
Vandetanib (ZD6474), a dual inhibitor of vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) tyrosine kinases: current status and future directions (English)
Fabiano Falasconi
Gianfranco De Feo
Antonia Del Giudice
Jane Bryce
Ermelinda De Maio
Francesco Perrone
Maria Carmela Piccirillo